Eugene

[email protected]

LATEST

Celgene Chairman To Retire, Current CEO to Take Role
By

By
Celgene Executive Chairman Bob Hugin plans to retire after 19 years of service and will step down from Celgene’s board of directors, effective February 5, 2018. Chief Executive Officer (CEO)…

FDA Outlines Steps to Mitigate Overprescribing of Opioid Drugs and Changes to Packaging
By

By

Novartis Leads Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Novartis. Editor’s Note: This article was updated on a continuous basis for news announced from Wednesday…

Mylan, Biocon, Roche, GSK, and Takeda Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Mylan, Biocon, Roche, GlaxoSmithKline, and Takeda. Editor’s Note: This article was updated on…

Novartis, Spark Therapeutics in Gene-Therapy Pact
By

By
Novartis and Spark Therapeutics, a Philadelphia, Pennsylvania-headquartered biopharmaceutical company, have signed a license pact to develop and commercialize investigational voretigene neparvovec, a vision-loss drug, outside the US while Spark Therapeutics…

Dr. Reddy’s Formulation Facility Passes EU-GMP Re-Inspection
By

By
Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered pharmaceutical company, has passed a GMP re-inspection carried out by German regulators at its formulations manufacturing plant (Unit 2) in Bachupally, Hyderabad, India. The…

Shire Gets FDA OK for Tech Transfer for Drug-Product Mfg Process to Vienna Facility
By

By
The US Food and Drug Administration has granted approval for Shire’s technology transfer of the drug-product manufacturing process for Cinryze (C1 esterase inhibitor [human]) to its manufacturing site in Vienna,…

EMA Head Comments on Agency Relocation to Amsterdam in Wake of Brexit
By

By
The European Medicines Agency (EMA) Executive Director Guido Rasi commented on the agency’s relocation of the EMA from London to Amsterdam, the Netherlands in the wake of the decision of…

Sanofi To Acquire Biotech Company Ablynx for $4.8 Billion
By

By
Sanofi has agreed to acquire Ablynx, a Ghent, Belgium-based biopharmaceutical company focused on developing and commercializing proprietary therapeutic proteins based on single-domain antibody fragments, for approximately EUR 3.9 billion ($4.8…

Astellas Completes Acquisition of Mitobridge
By

By
Astellas Pharma has completed its previously announced acquisition of Mitobridge, a Cambridge, Massachusetts-headquartered company developing small-molecule therapeutics that improve mitochondrial functions, for up to $450 million. The deal was made…